Acquired reactive perforating collagenosis in a patient with multiple comorbidities: a case report from Palestine - Summary - MDSpire

Acquired reactive perforating collagenosis in a patient with multiple comorbidities: a case report from Palestine

  • By

  • Majd Mohsen

  • Eman Jaber

  • Qais Naserallah

  • Montaser Badran

  • Sameer Mtour

  • Sami Bannoura

  • Rabee Adwan

  • June 26, 2026

  • 0 min

Share

Objective:

To report a case of acquired reactive perforating collagenosis (ARPC) in a patient with multiple systemic comorbidities.

Approach:
  • Case Presentation: A 55-year-old male with decompensated heart failure, type-2 diabetes, chronic renal failure, and hyperparathyroidism presented with pruritic skin lesions.
  • Diagnosis: Histopathology confirmed ARPC through the identification of cup-shaped epidermal invaginations and transepidermal extrusion of modified collagen.
  • Treatment: The patient was treated with Dermovate, omalizumab, fexofenadine, and body moisturizers, alongside management for glucose control and renal function.
Key Findings:
  • The patient was diagnosed with ARPC for the first time in Palestine.
  • He exhibited multiple pruritic papules with central keratotic plugs.
  • Histopathological findings confirmed the diagnosis of ARPC.
Interpretation:

The case illustrates the coexistence of ARPC with systemic comorbidities.

Limitations:
  • Only one case is reported, limiting generalizability.
  • Follow-up showed minimal improvement in pruritus and no change in skin lesions.
Conclusion:

ARPC is a rare dermatologic condition that may occur alongside various systemic diseases, necessitating increased clinical awareness.

Original Source(s)

Related Content